Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Oncology

Respiratory

Inflammation
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

Nintedanib

Nintedanib

Format

Sort by

Reset all filters

COLL4B||Maintaining Treatment Adherence in CTD-ILD

3:37

COLL4B||ASK-OFEV-ILD-POP-14||ILDTalks PPF in CTD-ILD: How does nintedanib fit in with background_SG

Watch-now Opens in new tab

3:50

COLL4B||ASK-OFEV-ILD-ADV-13||ILDTalks PPF in CTD-ILD: How do we keep patients on treatment with_SG

Watch-now Opens in new tab

COLL4B||Nintedanib in RA-ILD: Insights from the INBUILD Trial

3:53

COLL4B||A2-R101||ASK-OFEV-PF-ACE-4||EM-SG-100114

Watch-now Opens in new tab

PDF

COLL4B||ILD Masterclass 2024 Post-Event Newsletter

Download Opens in new tab

1:25

Meet John: IPF Patient Journey

Watch-now Opens in new tab

1:27

Meet Daniel: RA-ILD Patient Journey

Watch-now Opens in new tab

Pagination

Load More

Home
Inflammation
Nintedanib

Sitemap

Therapeutic Area

Resources

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Singapore. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.